October 18-21, 2015Visit us at the world's premier radiation oncology conference in San Antonio, TX.
From screening and diagnosis to treatment and follow-up, Siemens leaves breast cancer no place to hide.
Engineered to meet the demanding chemistry workloads of the future – today!
Siemens FREEZEit technology means quicker workflow and more cases, even with hard-to-scan patients.
A cloud-based, multilab inventory-management system.
Siemens sponsors the U.S. News & World Report Hospital of Tomorrow Summit, October 18-20, 2015.
Identify infection earlier by detecting the HIV p24 antigen in addition to HIV antibodies with the ADVIA Centaur® HIV Ag/Ab Combo assay.
Breast cancer is the most common cancer in women. Early detection and reliable diagnosis are keys to survival. Now, wide-angle 3D breast tomosynthesis from Siemens is FDA-approved.
See what our executives are saying about the major challenges, trends, and opportunities in healthcare.
Note: to get a direct personal response, please contact us via our email form.